Pyc Therapeutics Ltd (PYC.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2010 | 06-2009 | 06-2008 | 06-2007 | 06-2006 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -143 | -5 | -130 | -67 | -52 |
| Investing Cash Flow | $-143 | $-5 | $-130 | $-67 | $-52 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,240 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -5 |
| Common Stock Issued | 2,100 | 2,600 | 5,173 | 4,077 | 52 |
| Common Stock Repurchased | -120 | -195 | -207 | -188 | N/A |
| Other Financing Activity | 0 | 80 | 0 | 0 | -53 |
| Financing Cash Flow | $1,980 | $3,725 | $4,966 | $3,889 | $-5 |
| Beginning Cash Position | 3,073 | 3,232 | 3,369 | 2,639 | 5,505 |
| End Cash Position | 1,281 | 3,073 | 3,232 | 3,369 | 2,639 |
| Net Cash Flow | $-1,792 | $-159 | $-137 | $730 | $-2,866 |
| Free Cash Flow | |||||
| Capital Expenditure | -159 | -5 | -130 | -67 | -52 |
| Free Cash Flow | -159 | -5 | -130 | -67 | -52 |